标普和纳斯达克内在价值 联系我们

Alfresa Holdings Corporation ARHCF OTC

Other OTC • Healthcare • Medical - Distribution • JP • USD

SharesGrow Score
64/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Alfresa Holdings Corporation (ARHCF) 当前追踪市盈率 (P/E) 为 0.1, 前瞻市盈率为 0.1. 追踪盈利收益率为 1,250.00%, 前瞻盈利收益率 1,666.67%.

本页证实的标准:

  • VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.1); 盈利收益率超过债券收益率 (1,250.00%).
  • 前瞻市盈率 0.1 (低于追踪值 0.1) — 分析师预计盈利将增长,这将改善估值。
  • 追踪盈利收益率 1,250.00% — 超过典型债券收益率(约4.3%),使股票相对固定收益更具吸引力。 前瞻收益率改善至 1,666.67% 随着盈利恢复。

SharesGrow 综合评分: 62/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score
64/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
未來
N/A
No coverage
过去
100/100
→ Income
健康
83/100
Debt-to-Equity & liquidity
→ Health
护城河
43/100
→ Income
成长
30/100
→ Income
收入
30/100
→ Income

估值概览 — ARHCF

估值倍数
P/E (TTM)0.1
前瞻 P/E0.1
PEG 比率N/A
前瞻 PEG0.00
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$147.54
前瞻 EPS(预估)$193.78
每股账面价值$0.00
每股营收$15,950.69
每股自由现金流$0.00
收益率与内在价值
盈利收益率1,250.00%
Forward Earnings Yield1,666.67%
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $158.99 $2.58T $34.98B 1.4%
2017 $142.58 $2.55T $30.89B 1.2%
2018 $164.25 $2.6T $35.59B 1.4%
2019 $195.79 $2.64T $41.7B 1.6%
2020 $190.26 $2.7T $40.27B 1.5%
2021 $115.75 $2.6T $24.5B 0.9%
2022 $153.57 $2.59T $32.18B 1.2%
2023 $127.42 $2.7T $25.79B 1%
2024 $154.13 $2.86T $29.56B 1%
2025 $147.54 $2.96T $27.39B 0.9%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言